These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 32533996)

  • 1. Pathophysiology of negative symptom dimensions of schizophrenia - Current developments and implications for treatment.
    Bègue I; Kaiser S; Kirschner M
    Neurosci Biobehav Rev; 2020 Sep; 116():74-88. PubMed ID: 32533996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individual negative symptoms and domains - Relevance for assessment, pathomechanisms and treatment.
    Kaiser S; Lyne J; Agartz I; Clarke M; Mørch-Johnsen L; Faerden A
    Schizophr Res; 2017 Aug; 186():39-45. PubMed ID: 27453425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive Emotions Program for Schizophrenia (PEPS): a pilot intervention to reduce anhedonia and apathy.
    Favrod J; Nguyen A; Fankhauser C; Ismailaj A; Hasler JD; Ringuet A; Rexhaj S; Bonsack C
    BMC Psychiatry; 2015 Sep; 15():231. PubMed ID: 26419356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurophysiological correlates of Avolition-apathy in schizophrenia: A resting-EEG microstates study.
    Giordano GM; Koenig T; Mucci A; Vignapiano A; Amodio A; Di Lorenzo G; Siracusano A; Bellomo A; Altamura M; Monteleone P; Pompili M; Galderisi S; Maj M;
    Neuroimage Clin; 2018; 20():627-636. PubMed ID: 30202724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two Factors, Five Factors, or Both? External Validation Studies of Negative Symptom Dimensions in Schizophrenia.
    Ahmed AO; Kirkpatrick B; Granholm E; Rowland LM; Barker PB; Gold JM; Buchanan RW; Outram T; Bernardo M; Paz García-Portilla M; Mane A; Fernandez-Egea E; Strauss GP
    Schizophr Bull; 2022 May; 48(3):620-630. PubMed ID: 35020936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing concepts in negative symptoms: primary vs secondary and apathy vs expression.
    Kirkpatrick B
    J Clin Psychiatry; 2014; 75 Suppl 1():3-7. PubMed ID: 24581452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two and five-factor models of negative symptoms in schizophrenia are differentially associated with trait affect, defeatist performance beliefs, and psychosocial functioning.
    Paul NB; Strauss GP; Gates-Woodyatt JJ; Barchard KA; Allen DN
    Eur Arch Psychiatry Clin Neurosci; 2023 Dec; 273(8):1715-1724. PubMed ID: 36633673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognizing primary vs secondary negative symptoms and apathy vs expression domains.
    Kirkpatrick B
    J Clin Psychiatry; 2014 Apr; 75(4):e09. PubMed ID: 24813410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The clinic of apathy in schizophrenia: a critical review of the issue].
    Yazbek H; Raffard S; Del-Monte J; Pupier F; Larue A; Boulenger JP; Gély-Nargeot MC; Capdevielle D
    Encephale; 2014 Jun; 40(3):231-9. PubMed ID: 23958346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A transnosographic approach of negative symptoms pathophysiology in schizophrenia and depressive disorders.
    Guessoum SB; Le Strat Y; Dubertret C; Mallet J
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Apr; 99():109862. PubMed ID: 31927053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [History and current state of the problem of negative disorders (research of nosological period)].
    Smulevich AB; Lobanova VM; Voronova EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(2):122-130. PubMed ID: 33728861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving Pleasure and Motivation in Schizophrenia: A Randomized Controlled Clinical Trial.
    Favrod J; Nguyen A; Chaix J; Pellet J; Frobert L; Fankhauser C; Ismailaj A; Brana A; Tamic G; Suter C; Rexhaj S; Golay P; Bonsack C
    Psychother Psychosom; 2019; 88(2):84-95. PubMed ID: 30783071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network Analysis Reveals the Latent Structure of Negative Symptoms in Schizophrenia.
    Strauss GP; Esfahlani FZ; Galderisi S; Mucci A; Rossi A; Bucci P; Rocca P; Maj M; Kirkpatrick B; Ruiz I; Sayama H
    Schizophr Bull; 2019 Sep; 45(5):1033-1041. PubMed ID: 30256991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Negative symptoms in schizophrenia - overview and practical implications].
    Klaus F; Dorsaz O; Kaiser S
    Rev Med Suisse; 2018 Sep; 14(619):1660-1664. PubMed ID: 30230774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Negative Symptoms in Schizophrenia - an Overview].
    Klaus F; Kaiser S; Kirschner M
    Ther Umsch; 2018 Jun; 75(1):51-56. PubMed ID: 29909762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventral striatal hypoactivation is associated with apathy but not diminished expression in patients with schizophrenia.
    Kirschner M; Hager OM; Bischof M; Hartmann MN; Kluge A; Seifritz E; Tobler PN; Kaiser S
    J Psychiatry Neurosci; 2016 Apr; 41(3):152-61. PubMed ID: 26395814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evolution of the concept of apathy: the need for a multifactorial approach in schizophrenia].
    Del-Monte J; Capdevielle D; Gély-Nargeot MC; Yazbek H; Pupier F; Boulenger JP; Raffard S
    Encephale; 2013 May; 39 Suppl 1():S57-63. PubMed ID: 23351930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is it more effective for anhedonia and avolition? A systematic review and meta-analysis of non-invasive brain stimulation interventions for negative symptoms in schizophrenia.
    Chen Y; Li Z; Yan C; Zou L
    CNS Neurosci Ther; 2024 Mar; 30(3):e14645. PubMed ID: 38432851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Latent Structure of Negative Symptoms in Schizophrenia.
    Strauss GP; Nuñez A; Ahmed AO; Barchard KA; Granholm E; Kirkpatrick B; Gold JM; Allen DN
    JAMA Psychiatry; 2018 Dec; 75(12):1271-1279. PubMed ID: 30208377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative symptoms of schizophrenia: new developments and unanswered research questions.
    Galderisi S; Mucci A; Buchanan RW; Arango C
    Lancet Psychiatry; 2018 Aug; 5(8):664-677. PubMed ID: 29602739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.